HOUSTON--(BUSINESS WIRE)--CompanionDx Reference Lab, a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted next generation sequencing (NGS) and epigenomics testing, is proud to join forces with RegenWell Holdings, a Georgia-based integrated healthcare provider. The partnership will bring CompanionDx Lab’s personalized medicine and precision therapy genomic testing to the point of care to deliver reduced healthcare costs and improved patient outcomes by optimizing drug selection and dosing based on the genetic makeup of each individual patient.
Help employers find you! Check out all the jobs and post your resume.
